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DEXAMETHASONE SUPRESSION TEST IN DEPRESSIVES 










A cohort of endogenous depressives and normal controls were studied to examine the role of DST in de-
pressives treated with ECT. Weekly DST estimation was done and depression was assessed on HRS-D. 73.6% 
patients were found to be non suppressors as compared to controls in whom 16.7% were non suppressors. 60% 
DST positive patients showed clinical improvement while 50% DST negative did not show improvement. This 
proves the notion that DST is a state dependent biological marker of endogenous depressed state. 
Introduction 
The advancement in biological 
psychiatry has led to many exciting de-
velopments; the most important till date 
has been the premise to diagnose some 
melancholies by a simple laboratory test: 
the Dexamethasone Suppression Test 
(DST). The pioneer work in this field was 
done by D.B.J. Carroll who had described 
it as a laboratory marker of endogenous 
depressed state (Carroll et al 1980). The 
evidence for its state relationship is fairly 
strong. Response to DST is non suppres-
sive during melancholic episode and sup-
pressive during euthymion (Caroll 1972, 
Gredenetall980.) 
DST can be used in the monitoring of 
antidepressant treatment (Greden et al 
1983), predicting new episodes (Carroll 
1987), diagnosing affective disorders in 
early childhood (Greden and Carroll 
1979), masked depression and 
pseudodementia (Grunchams et al, 1983). 
The DST tends to normalize as depre-
ssion subsides (Albala et al 1981, De-
vanand et al 1987) and may even normalize 
well before clinical improvement which 
may have a predictive value for good treat-
ment response. 
A favourable electroconvulsive 
therapy (ECT) response was predicted 
when an abnormal DST result was noted at 
discharge (Coryell 1982). However, 
Coryell and Zimmerman (1983) suggested 
that ECT may be having immediate effect 
on hypothalmic structures which invali-
date use of DST as a predictor of response. 
The present study was done to find 
out the relationship between DST and clin-
ical improvement of depressives treated 
with ECT. 
Material and Methods 
The patients of the experimental 
group comprised of 30 patients (drawn 
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try, K.G's. Medical College, Lucknow) 
diagnosed as Manic Depressive Psychosis 
- depression (ICD) and fulfilling the Re-
search Diagnostic Criteria (Spitzer et al 
1978) for Major Depression. The sample 
were between the ages of 17 - 55 years and 
were evaluated on a present selection 
criteria. Thirty normal controls were also 
studied. 
The patients of the experimental 
group were evaluated on Hamilton 
Psychiatric Rating Scale for depression 
(HRS-D) (Hamilton 1960) and those hav-
ing a score of 17 or more were further 
studied. The patients were given biweekly 
direct ECT's upto a maximum of 10 treat-
ments. However, the treatment was stop-
ped when HRS-D levels equalised 5 or fell 
below it. 
DST estimation was done by giving 1 
mg of dexa-methasone to the patients at 11 
p.m. followed by sampling of blood at 4 
p.m. on the following day. The plasma was 
separated and Cortisol levels was estimated 
by spectro-flurometric method (Mat-
tingloy 1962). The DST (cut off 13 mg/dl) 
was done one day and, thereafter on day 7, 
14, 21, 28 and 35. The ECT was stopped 
when the patient recorded 5 or less on 
HRS-D. The DST was estimated 72 hours 
after the last ECT so as to exclude any pos-
sibility of an increased Cortisol levels due 
to ECT itself. 
The control group consisted of 30 nor-
mal subjects, who were evaluated clini-
cally, as well as, on Cornell Medical Index, 
to exclude any possibility of psychiatric ill-
ness. Only one point DST of the control 
group was done. 
Apart from giving nitrazepam on an 
SOS basis no extra medication was given to 
the patients. 
Results 
Thirty patients each of the experimen-
tal and control group completed the study. 
The mean age of the experimental group 
was 38.6 years (range 20-55 years) while it 
was 32.9 years (range 20 - 49 years) for the 
controls. In majority of the patients the ill-
ness started between 26 and 45 years when 
they had their first episode. 60% patients 
had no past history of affective illness. The 
mean plasma Cortisol levels of the depre-
ssed and control group was 18.9 and 11.9 
mg/Dl respectively. No correlation was 
found between age and plasma Cortisol 
levels (Table 1). 
Table 1 
DST in Experimental and Control Group 
Experimental Group Control 
N = 30 N = 30 
No. % No. % 
Suppressors 8 26.7 25 83.3 
Non Suppressor 22 73.3 5 16.7 
Thirty depressed patients and thirty 
controls were compared for DST. 73.3% 
of depressed patients were non suppres-
sors prior to treatment while only 16.7% of 
controls were non suppressors. 26.7% of 
the patients were suppressors of DST, as 
compared to 83.3% that of controls. 
76.9% patients were males while 
23.1% were females and in both groups 
about one third were suppressors on DST 
which shows that DST is not dependent on 
sex. When DST was compared with the clin-
ical improvement (HRS-D) in the improved 
group at the beginning and at the end of the 
study it was found that 82.6% of the patients 
were non suppressors on DST and their 
mean HRS-D was 29.1 and at the end 30.4% 
were non suppressors (Table 2). 
When the above comparison was 
done in the norj improved group it was 
found that 57.1% patients were suppres-
sors on DST with the corresponding mean 
HRS-D of 28.7 while at the end of the study S.L. VARMAETAL 355 
Table 2 
DST and clinical improvement of the patients of 
improved and non improved group 
Improved Group Non Improved Group 
N = 23 N = 7 
Group PreTt. At the end PreTt. At the end 
% No. No. 
Suppressor No. 4(17.4%) 16(69.6%) 4(57.1%) 7(100%) 
HRS-D 20.5 3.5 28.7 13.2 
(Mean) 
NonSuppressor No. 19(82.6%) 7(30.4%) 3(42.9%) 0 
HRS-D 29.1 14.1 26.2 
(Mean) 
100% patients were suppressors with mean 
HRS-D of 13.3 
26.7% patients were suppressors 
(13.3% each of improved and non im-
proved group) before starting the treat-
ment and they remained suppressors till 
the end of the study. Whereas 73.3% were 
non suppressors prior to treatment out of 
which one sixth were in the non improved 
group while at the end of the study 23.1% 
were still non suppressors and they were 
those patients who belonged to the im-
proved group. 
23 patients of the experimental group 
improved with ECT while 7 did not im-
prove. 15 patients (50%) required 5-6 
ECTs for improvement, 6 patients (20%) 
required 7-8 ECTs while 2 patients re-
quired 9-10 ECTs. 7 patients (23.3%) 
however, did not show improvement even 
after 10 ECTs. 
Discussion 
There are several reports relating to 
DST and depression but only few reports 
are available relating to DST, depression 
and ECT especially in India. Most of the 
studies have evaluated DST on depressives 
treated with antidepressant drugs. As en-
dogenous depressives show good response 
to ECT, even quicker than antidepressant 
drugs, we had planned to study the role of 
DST in depressives treated when direct 
ECTs only. 
Several methods of Cortisol estima-
tions are available, like calorimetry, 
flurometry, radio immunossay and com-
petitive protein binding methods. Spec-
trofluometric methods was employed by 
Carroll et al (1968) and Carroll and Davies 
(1970). The present study also employed 
spectro-fluorometric method as it was the 
only available method till then, in the local 
laboratories. We have taken 13 mg/dl as 
cut off point for DST (Varma 1985). 
There was no significant correlation 
found between age and post de-
xamethasone plasma Cortisol level in this 
study. Similar findings have been reported 
by other workers. (Greden et al 1983, Car-
roll and Mendels 1976, Carroll et al 1981) 
which indicate that patients of depression 
could be identified irrespective of age. A 
positive correlation was observed between 
age and DST in patients above the age of 
50 years (Sachar et al 1975) leading to a 
possibility that they could be hypersec-
retors of Cortisol. 
It was also found that the number of 
episodes of depression (single and multi-
ple) do not have a significant bearing on 
the DST which was also reported by 356 DEXAMETHASONE SUPPRESSION TEST IN DEPRESSIVES TREATED WITH ECT. 
Schlesser et al (1980) and Nelson et al 
(1982). This findings supports the notion 
that DST is a state dependent rather than 
trait dependent biological marker. 
83.3% of the normal controls were 
suppressors on DST while only 16.7% 
were non suppressors. This is in agreement 
with several studies (Carroll et al 1976). 
Amserdam et al (1982) who have found 
non suppressor DST in 4 - 16% of the nor-
mal population which suggests that they 
may be hypersecretors of Cortisol due to 
factors other than depression. On the 
other hand in the depressed group 73.3% 
patients were non suppressors suggesting 
an hyperactive H-P-A axis activity. This 
finding is supported by many studies. 
When both the improved and non im-
proved group patients were evaluated, it 
was found that 73.3% were non suppres-
sors prior to treatment while 23.1% were 
still non suppressors at the end of the study 
and they were those patients who belonged 
to the improved group (Table 2). Out of 
the 26.7% who were suppressors, 13.3% 
went on to show improvement and still 
they remained suppressors in the end also. 
These findings go on to prove a point that 
atleast 60% patients who were DST posi-
tive initially, will show reversal of DST on 
clinical improvement thus confirming the 
notion that DST is a state related biologi-
cal marker. Moreover, there is a possibility 
that, a prediction could be made in about 
two-third of the patients of non suppressor 
group, that they will show clinical im-
provement. 
Among the suppressor group about 
50% patients did not show clinical im-
provement, nor change in DST status. This 
also proves the above point by a negative 
statement that about 50% DST negative 
patients would not show any change in 
their clinical or DST status. 
Summarising the findings we can say 
that DST is a useful state dependent 
biological marker in about 50-60% pa-
tients of endogenous depression but its 
predictive value about treatment response 
awaits more research. 
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